ZA200704449B - Perorally administrable antimicrobial composition - Google Patents
Perorally administrable antimicrobial compositionInfo
- Publication number
- ZA200704449B ZA200704449B ZA200704449A ZA200704449A ZA200704449B ZA 200704449 B ZA200704449 B ZA 200704449B ZA 200704449 A ZA200704449 A ZA 200704449A ZA 200704449 A ZA200704449 A ZA 200704449A ZA 200704449 B ZA200704449 B ZA 200704449B
- Authority
- ZA
- South Africa
- Prior art keywords
- antimicrobial composition
- composition
- lactulose
- perorally administrable
- antibiotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2004126203/15A RU2284832C2 (ru) | 2004-08-30 | 2004-08-30 | Антимикробная композиция для перорального введения |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200704449B true ZA200704449B (en) | 2008-08-27 |
Family
ID=36000449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200704449A ZA200704449B (en) | 2004-08-30 | 2007-05-30 | Perorally administrable antimicrobial composition |
Country Status (21)
Country | Link |
---|---|
US (1) | US8231871B2 (fr) |
EP (1) | EP1790357B1 (fr) |
JP (1) | JP5062480B2 (fr) |
CN (1) | CN101031321B (fr) |
AT (1) | ATE410185T1 (fr) |
AU (1) | AU2005280704B2 (fr) |
BR (1) | BRPI0514708A (fr) |
CA (1) | CA2620919C (fr) |
DE (1) | DE602005010280D1 (fr) |
DK (1) | DK1790357T3 (fr) |
EA (1) | EA010199B1 (fr) |
ES (1) | ES2314708T3 (fr) |
MX (1) | MX2007002291A (fr) |
NZ (1) | NZ554212A (fr) |
PL (1) | PL1790357T3 (fr) |
PT (1) | PT1790357E (fr) |
RU (1) | RU2284832C2 (fr) |
TR (1) | TR200703565T1 (fr) |
UA (1) | UA85608C2 (fr) |
WO (1) | WO2006025767A2 (fr) |
ZA (1) | ZA200704449B (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004261143B2 (en) | 2003-07-25 | 2009-11-05 | Allergan Pharmaceuticals International Limited | A doxycycline metal complex in a solid dosage form |
AU2006206359B2 (en) * | 2005-01-21 | 2011-03-31 | Allergan Pharmaceuticals International Limited | A tetracycline metal complex in a solid dosage form |
US20110200668A1 (en) * | 2008-03-18 | 2011-08-18 | Aleksander Vladimirovich Dikovskiy | Pharmaceutical composition for preventing dysbiosis associated with enteral administration of antibiotics |
BRPI0822359A2 (pt) | 2008-03-18 | 2015-07-14 | Aleksander Vladimirovich Dikovskiy | Composição farmacêutica de antibióticos e prebióticos para prevenir e tratar disbiose durante terapia antibacteriana |
AU2014262710B2 (en) | 2013-05-07 | 2019-09-12 | Perkinelmer Health Sciences, Inc. | Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions |
CN113476472A (zh) * | 2021-07-22 | 2021-10-08 | 中国科学院烟台海岸带研究所 | 一种用于缓解肠道紊乱的益生元组合物 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1582068A (en) * | 1977-12-09 | 1980-12-31 | Morinaga Milk Industry Co Ltd | Powder composition comprising viable bifidobacteria cells containing powder and lactulose containing powder |
EP0169700B1 (fr) * | 1984-07-23 | 1990-05-16 | Eli Lilly And Company | Compositions pharmaceutiques de ceftazidime |
US4963141A (en) * | 1985-08-16 | 1990-10-16 | Alza Corporation | Dispensing system for administering beneficial agent formulation to ruminants |
JPH0614862B2 (ja) * | 1987-05-22 | 1994-03-02 | 東京田辺製薬株式会社 | ビフィドバクテリウム菌の増殖促進剤 |
JPS6483025A (en) * | 1987-09-24 | 1989-03-28 | Fujio Hayashi | Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent |
IE68841B1 (en) * | 1988-03-18 | 1996-07-10 | Duphar Int Res | Method of preparing solid lactulose |
FI87880C (fi) * | 1990-06-27 | 1993-03-10 | Valio Meijerien | Foder som befraemjar tillvaexten och tarmfunktionen hos djur |
ES2188657T3 (es) * | 1994-04-22 | 2003-07-01 | Yamanouchi Pharma Co Ltd | Sistema para la liberacion especifica en el colon de un farmaco. |
AU3691297A (en) * | 1996-08-15 | 1998-03-06 | Losan Pharma Gmbh | Easy to swallow oral medicament composition |
JPH10194975A (ja) * | 1997-01-10 | 1998-07-28 | Morinaga Milk Ind Co Ltd | 肝疾患治療剤 |
IT1297538B1 (it) * | 1997-08-01 | 1999-12-17 | Francesco Vicidomini | Enteroclisma di lattulosio/lattitolo con o senza aggiunta di neomicina per la cura della encefalopatia portosistemica acuta |
FR2769839B1 (fr) * | 1997-10-21 | 1999-12-17 | Odette Mercedes Salsarulo | Composition anhydre a base de lactulose |
US6368591B2 (en) * | 1998-05-15 | 2002-04-09 | Shanghai Sine Pharmaceutical Corporation Ltd. | Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof |
RU2131260C1 (ru) * | 1998-10-14 | 1999-06-10 | Плисов Николай Валерьевич | Препарат для лечения желудочно-кишечных заболеваний |
CA2362016A1 (fr) * | 1999-03-03 | 2000-09-08 | Kenneth Philip Moder | Complexes d'echinocandine/glucide |
WO2000074720A1 (fr) * | 1999-06-09 | 2000-12-14 | Mochida Pharmaceutical Co., Ltd. | Systeme de liberation dans les voies digestives inferieures |
-
2004
- 2004-08-30 RU RU2004126203/15A patent/RU2284832C2/ru not_active IP Right Cessation
-
2005
- 2005-08-25 BR BRPI0514708-5A patent/BRPI0514708A/pt active Search and Examination
- 2005-08-25 TR TR2007/03565T patent/TR200703565T1/xx unknown
- 2005-08-25 UA UAA200702431A patent/UA85608C2/ru unknown
- 2005-08-25 NZ NZ554212A patent/NZ554212A/en not_active IP Right Cessation
- 2005-08-25 CA CA2620919A patent/CA2620919C/fr not_active Expired - Fee Related
- 2005-08-25 PL PL05782960T patent/PL1790357T3/pl unknown
- 2005-08-25 DE DE602005010280T patent/DE602005010280D1/de active Active
- 2005-08-25 DK DK05782960T patent/DK1790357T3/da active
- 2005-08-25 AT AT05782960T patent/ATE410185T1/de active
- 2005-08-25 ES ES05782960T patent/ES2314708T3/es active Active
- 2005-08-25 AU AU2005280704A patent/AU2005280704B2/en not_active Ceased
- 2005-08-25 MX MX2007002291A patent/MX2007002291A/es active IP Right Grant
- 2005-08-25 WO PCT/RU2005/000434 patent/WO2006025767A2/fr active Application Filing
- 2005-08-25 CN CN2005800291966A patent/CN101031321B/zh not_active Expired - Fee Related
- 2005-08-25 EA EA200700357A patent/EA010199B1/ru not_active IP Right Cessation
- 2005-08-25 PT PT05782960T patent/PT1790357E/pt unknown
- 2005-08-25 JP JP2007529762A patent/JP5062480B2/ja not_active Expired - Fee Related
- 2005-08-25 US US11/661,472 patent/US8231871B2/en not_active Expired - Fee Related
- 2005-08-25 EP EP05782960A patent/EP1790357B1/fr active Active
-
2007
- 2007-05-30 ZA ZA200704449A patent/ZA200704449B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0514708A (pt) | 2008-06-24 |
US8231871B2 (en) | 2012-07-31 |
EP1790357A4 (fr) | 2007-11-07 |
ES2314708T3 (es) | 2009-03-16 |
WO2006025767A8 (fr) | 2007-04-05 |
DE602005010280D1 (de) | 2008-11-20 |
PL1790357T3 (pl) | 2009-03-31 |
MX2007002291A (es) | 2008-02-12 |
RU2284832C2 (ru) | 2006-10-10 |
EP1790357B1 (fr) | 2008-10-08 |
CA2620919C (fr) | 2014-10-14 |
RU2004126203A (ru) | 2006-02-10 |
CN101031321B (zh) | 2010-12-15 |
AU2005280704A1 (en) | 2006-03-09 |
ATE410185T1 (de) | 2008-10-15 |
CN101031321A (zh) | 2007-09-05 |
EA200700357A1 (ru) | 2008-06-30 |
EA010199B1 (ru) | 2008-06-30 |
DK1790357T3 (da) | 2009-02-02 |
EP1790357A2 (fr) | 2007-05-30 |
WO2006025767A2 (fr) | 2006-03-09 |
WO2006025767A3 (fr) | 2006-08-17 |
PT1790357E (pt) | 2008-12-31 |
US20070254023A1 (en) | 2007-11-01 |
NZ554212A (en) | 2009-08-28 |
CA2620919A1 (fr) | 2006-03-09 |
TR200703565T1 (tr) | 2007-08-21 |
UA85608C2 (ru) | 2009-02-10 |
JP5062480B2 (ja) | 2012-10-31 |
JP2008511622A (ja) | 2008-04-17 |
AU2005280704B2 (en) | 2010-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200704449B (en) | Perorally administrable antimicrobial composition | |
CA2339991A1 (fr) | Microemulsions comme formes pharmaceutiques solides destinees a une administration orale | |
CA2115381A1 (fr) | Rifaximine et compositions pharmaceutiques en contenant utilisees dans le traitement de la dyspepsie gastrique causee par helicobacter pylori | |
WO2006035418A3 (fr) | Produits de combinaison | |
JP2005524658A5 (fr) | ||
WO2001041770A3 (fr) | Compositions d'eplerenone nanoparticulaire | |
WO2007070677A3 (fr) | Compositions pharmaceutiques et procedes de traitement ou de prevention d'une maladie associee a l'oxalate | |
HUP0402394A2 (hu) | Kolloid szilícium-dioxidot tartalmazó gyógyszerkompozíciók | |
MY148466A (en) | Granule formulation | |
WO2005117895A3 (fr) | Compositions contenant de la meloxicame | |
CA2417106A1 (fr) | Derives de la piperazine | |
WO2006021160A8 (fr) | Système de relargage de médicament auto-émulsifiant à base de butylbenzènephtaléine, méthode de préparation et applications d’un tel système | |
HUP0302622A2 (hu) | Ellenőrzött hatóanyag-leadású, biológiailag lebontható mikrorészecskék, amelyek csökkentett molekulatömegű, tisztított amilopektinalapú keményítőt tartalmaznak | |
WO2003053399A3 (fr) | Procedes de granulation par voie humide d'azithromycine | |
CA2326048A1 (fr) | Principe actif en suspension perorale | |
WO2008013630A3 (fr) | Agent pharmaceutique à base d'aluminosilicate de calcium | |
BR0111868A (pt) | Composições farmacêuticas | |
IL260229B2 (en) | Suspension formulations of st-246 (tecovirimate monohydrate) | |
WO2008099615A1 (fr) | Composition pharmaceutique contenant une suspension à base d'huile en fines particules | |
WO2003066022A3 (fr) | Preparation pharmaceutique stable pour le traitement des troubles gastro-intestinaux | |
US20180250227A1 (en) | Nanosuspension formulation | |
WO2005009407A3 (fr) | Formulations pharmaceutiques d'olanzapine administrees par voie orale | |
BG103958A (en) | Pharmaceutical compositions of thioxanide and nitazoxanide | |
MXPA03010945A (es) | Mejoramiento de la biodisponibilidad oral de forumulaciones no esterificadas de esteres de profarmacos con lecitina. | |
WO2003039437A3 (fr) | Preparation pharmaceutique d'administration orale contenant du paclitaxel encapsule dans des liposomes |